Skip to main content
Skip to navigation

Teva Facing Probe for Potential False Claims Act Violations

By Jaclyn Jaeger2014-02-11T12:16:00

THIS IS MEMBERS-ONLY CONTENT

You are not logged in and do not have access to members-only content.

If you are already a registered user or a member, SIGN IN now.

Related articles

Article
Teva to pay $54M in FCA whistleblower settlement

2020-01-07T20:01:00Z By Jaclyn Jaeger

Teva Pharmaceuticals has reached a $54 million settlement in a lawsuit filed by two whistleblowers over allegations the drug company bribed physicians through numerous “sham” speaker programs in exchange for prescribing Teva drugs.
News Brief
Interactive Brokers to pay $11.8M to settle thousands of U.S. sanction violations

2025-07-18T16:33:00Z By Aaron Nicodemus

A brokerage and investment firm will pay $11.8 million for providing services to individuals under U.S. sanctions, as well as people located in countries sanctioned by the U.S.
News Brief
Delta to pay $8.1 million over False Claims Act violations tied to pandemic aid

2025-07-16T20:11:00Z By Oscar Gonzalez

Delta Air Lines agreed to pay $8.1 million over allegations it violated the False Claims Act by exceeding employee compensation limits it agreed to when taking federal pandemic aid money.